Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harlan Bioproducts for Science was a specialized division of Harlan Laboratories that provided high-quality biological products and contract services to the global research community. The company focused on the production of monoclonal and polyclonal antibodies, as well as the supply of animal-derived serums, tissues, and proteins. They offered custom production services, including hybridoma development and large-scale antibody manufacturing under GMP-compliant conditions. Following the merger of Harlan with Huntingdon Life Sciences in 2015, the entity became part of Envigo. These operations were further integrated into Inotiv following its acquisition of Envigo in 2021, continuing to support drug discovery and development through specialized biological reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harlan Bioproducts for Science.